Technology and policy often make combustible bedfellows for farming in India. Add cotton to the mix, and things tend to get even more fiery. Two polar opposites are caught in the latest flare-up: Monsanto, the USD15 billion agri-biotech multinational with a fraught past, whose acquisition by Bayer finally has EU regulatory approval. And Nuziveedu Seeds, a relatively tiny hybrid-seeds
Some Features are not available in your region.
You have limited access to archive
You are currently on the quarterly membership plan which gives you access to 3 months of archives.This story is older than 3 months.
GO TO HOMEPAGE
Sign in to read the full article
SIGN IN
Why Subscribe?
Insight-rich storytelling you won't find elsewhere by the finest team of business writers
Great conversations among an elite community of opinion leaders
A great reading experience across all your devices
Exclusive access to members-only events
The setting here is much like the pharmaceutical industry about a decade ago. A few Indian pharmaceutical companies had then vehemently opposed ‘questionable’ patents on life-saving drugs and had them invalidated. A repeat in the agriculture sector, more specifically cotton, is in play. Except we don’t know yet which party will emerge triumphant. ( Graphic by Hemal Sheth)
Technology and policy often make combustible bedfellows for farming in India. Add cotton to the mix, and things tend to get even more fiery. Two polar opposites are caught in the latest flare-up: Monsanto, the USD15 billion agri-biotech multinational with a fraught past, whose acquisition by Bayer finally has EU regulatory approval. And Nuziveedu Seeds, a relatively tiny hybrid-seeds
Sign in to read the full article
SIGN IN
Why Subscribe?
Insight-rich storytelling you won't find elsewhere by the finest team of business writers
Great conversations among an elite community of opinion leaders
A great reading experience across all your devices
Exclusive access to members-only events
The setting here is much like the pharmaceutical industry about a decade ago. A few Indian pharmaceutical companies had then vehemently opposed ‘questionable’ patents on life-saving drugs and had them invalidated. A repeat in the agriculture sector, more specifically cotton, is in play. Except we don’t know yet which party will emerge triumphant. ( Graphic by Hemal Sheth)
Getty Images
CONTRIBUTORS WHO HAVE COMMENTED ON THIS STORY
test